Covering drugs from discovery to launch, pipeline information from IQVIA supports better decision-making from product launch to optimization. From evaluating future threats to identifying new opportunities for licensing partnerships, IQVIA collates and manages information on drugs in discovery to launch from more than 7,500 companies. It's a powerful way to monitor pipelines of competitors or target companies.
The pharmaceutical industry is in both the best and worst of times. Breakthroughs in both science and technology are filling pipelines and fueling profitability. But competition and specialization are growing, along with costs.
IQVIA gives you data and analytics that let you precisely align your development strategy to critical market drivers, by letting you:
Discover unrealized connections and manage your product across the entire lifecycle, from research and development, compliance to launch and commercialization.
Build and compare potential pipeline development strategies quickly and transparently.
Go beyond the numbers to analytics-driven insights using artificial intelligence, machine learning and healthcare expertise.
Discover proven strategies and insights refined over more than 5,000 launches around the world.
Understand how payers, providers, and patients define value, and accelerate market access for new and innovative products.